December 2, 2021 by Business Novartis expects new drugs to boost sales Novartis has said it is confident of delivering annual revenue growth of 4% or higher until 2026, as it banks on multi-billion dollar sales of experimental and approved drugs including arthritis and psoriasis medicine Cosentyx. From our friends over at the : Business You can see the Full Story: Click Here